Resmed (RMD) Other Non-Current Assets (2010 - 2026)
Resmed (RMD) posted Other Non-Current Assets of $210.7 million for Q1 2026, up 8.69% on a QoQ basis from $193.9 million in Q4 2025, and up 20.67% year-over-year from $174.6 million in Q1 2025.
Resmed (RMD) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Resmed's Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $210.7 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 20.67% year-over-year to $210.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $210.7 million (up 20.67% YoY) and the FY2025 annual result came in at $185.8 million, down 34.56% from the prior year.
- Other Non-Current Assets was $210.7 million for Q1 2026 at Resmed, up from $193.9 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $284.0 million in Q2 2024 and bottomed at $169.4 million in Q1 2022.
- A 5-year average of $225.0 million and a median of $210.7 million in 2026 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 12772.93% — and 2025, when it slumped 37.03%.
- Resmed's Other Non-Current Assets stood at $260.2 million in 2022, then advanced by 6.02% to $275.8 million in 2023, then sank by 34.31% to $181.2 million in 2024, then rose by 7.01% to $193.9 million in 2025, then gained by 8.69% to $210.7 million in 2026.
- Business Quant data shows RMD's Other Non-Current Assets at $210.7 million in Q1 2026, $193.9 million in Q4 2025, and $189.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 376.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 23.08 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 210.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 672.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 848.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 39.83 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 692.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 210.73 Mn |
| Dec 31, 2025 | 193.88 Mn |
| Sep 30, 2025 | 189.84 Mn |
| Jun 30, 2025 | 185.84 Mn |
| Mar 31, 2025 | 174.63 Mn |
| Dec 31, 2024 | 181.18 Mn |
| Sep 30, 2024 | 278.85 Mn |
| Jun 30, 2024 | 284.00 Mn |
| Mar 31, 2024 | 277.33 Mn |
| Dec 31, 2023 | 275.82 Mn |
| Sep 30, 2023 | 265.11 Mn |
| Jun 30, 2023 | 262.45 Mn |
| Mar 31, 2023 | 270.87 Mn |
| Dec 31, 2022 | 260.16 Mn |
| Sep 30, 2022 | 173.43 Mn |
| Jun 30, 2022 | 171.75 Mn |
| Mar 31, 2022 | 169.40 Mn |
| Dec 31, 2021 | 2.02 Mn |
| Sep 30, 2021 | 162.99 Mn |
| Jun 30, 2021 | 160.92 Mn |